Cancer Vaccine Sustains 49 Percent Melanoma Reduction After 5 Years
NEW YORK, June 1, 2026 /PRNewswire/ -- The combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful in cutting the risk of skin cancer recurrence and death by 49 percent, a new study shows. This reduction was calculated five...
NEW YORK, June 1, 2026 /PRNewswire/ -- The combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful in cutting the risk of skin cancer recurrence and death by 49 percent, a new study shows. This reduction was calculated five...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.